Singulair is the first asthma managing medication prepared by using the active pharmaceutical ingredient called Montelukast Sodium, developed by the world’s leading Pharma major Merck & Co Inc. in over a decade which has been signified for use in children of 2 years and above age. When taken, the medication is also indicated for avoiding as well as treating on continuously for asthma. The drug is steroid-free and is recommended for dosing simply 1 tablet every evening or as prescribed by the doctor.

Singulair – Montelukast Sodium belongs to the group of the oral leukotrienes receptor antagonists which are designed to obstruct the leukotrienes functions in the lungs leading to the minimized constriction of the bronchial tissues and diminish inflammation in the affected areas. Leukotrienes are the groups of naturally producing chemicals in both that stimulate inflammation in asthma and seasonal allergic rhinitis besides other ailments wherein inflammation is vital, allergic reactions for instance. Such functions of this medication transform into reduced asthma attacks as well as decreased dosage of asthma related medications.

Singulair – Montelukast Sodium is widely prescribed for asthma and seasonal allergic rhinitis conditions and the drug starts effectively working between 3 and 14 days of taking the therapy. Thus in the eventualities of any acute asthma attack, this medication may not prove to be very effective as per the test results. The recommended dose size of Singulair – Montelukast Sodium includes 4mg, 5mg or 10mg tablets of which 4 and 5mg tablets are especially prescribed for the children and is advised to be taken every evening with or without foods.